Open menu Close menu Open Search Close search

Biafine Topical Emulsion (Orthoneutrogena)

  • Description
  • Indications and Usage
  • Contraindications
  • Warnings
  • Precautions
  • Dosage and Administration
  • Description (2)
  • How Supplied

    - Drugs index
    - Manufacturers
    - Feedback


    BIAFINE® is a water-based emulsion formulated for the dressing and management of superficial wounds, minor abrasions, dermal ulcers, donor sites, 1st and 2nd degree burns, including sunburns, and radiation dermatitis. When applied properly to a wound, BIAFINE® provides an optimum moist environment for the healing process and isolates the wound from harmful germs and other external contamination.


    BIAFINE® is indicated for use in:

    • Full Thickness Wounds, Pressure Sores, Dermal Ulcers including Lower Leg Ulcers
    • Superficial Wounds
    • 1st and 2nd Degree Burns, including Sunburns
    • Dermal Donor and Graft Site Management
    • Radiation Dermatitis
    • Minor Abrasions


    BIAFINE® is contraindicated for use on bleeding wounds, skin rashes related to food or medicine allergies, and when an allergy to one of the ingredients is known.


    • ln radiation therapy, BIAFINE® may be applied as directed by the treating physician. Do not apply 4 hours prior to a radiation session.
    • Do not apply BIAFINE® to dermal grafts until after the graft has successfully taken.
    • Keep out of the reach of children.


    • For the treatment of any dermal wound, consult a physician. Use BIAFINE® only as directed.
    • BIAFINE® is non-toxic, it is for topical use only and should not be ingested or taken internally.
    • BIAFINE® does not contain a sunscreen and should not be used prior to extended exposure to the sun.
    • The use of BIAFINE® on skin rashes due to allergies has not been studied sufficiently and therefore is not recommended.
    • Following the application of BIAFINE® a temporary tingling sensation may occur (10 to 15 minutes).
    • If clinical signs of infection are present, appropriate treatment should be initiated. If clinically indicated, use of BIAFINE® may be continued during the anti-infective therapy.
    • If condition does not improve within 10-14 days, consult a physician.
    • BIAFINE® may dissolve fuchsin when this dye is used to define the margins of the radiation fields to be treated.


    BIAFINE® is for topical use only as directed by a healthcare professional.

    Wounds, Abrasions, Full Thickness Wounds, Dermal Graft Site Management and Donor Site Management

    • Wash the affected area(s) with saline, clean water, or a suitable wound cleanser.
    • Apply BIAFINE® on and around the affected area(s) in thick layers 1/4 to 1/2 inch thick.
    • If applying gauze dressing, moisten the dressing lightly before application.
    • Reapply BIAFINE® as described above every 24 to 48 hours or as directed until the wound or lesion has healed fully.
    • For donor site management, apply BIAFINE® after skin removal and cover with a moist dressing. Reapply as directed.
    • For dermal graft site management, apply BIAFINE® to the graft site only after the graft has taken successfully. BIAFINE® can be washed away with a saline solution or clean water without causing damage to the newly formed tissues.

    1st and 2nd Degree Burns, Including Sunburns

    • Before application of BIAFINE® to burns, take precaution in removing any clothing in the affected area(s).
    • Apply BIAFINE® as soon as possible on and around the affected area(s), in a thick 1/4 to 1/2 inch layer until the skin no longer absorbs the product. A white waxy residue may remain. If pain from the burn persists, apply thinner layers of BIAFINE® until the pain has ceased.
    • Continue to apply BIAFINE® until the affected area(s) has healed completely.
    • Application of BIAFINE® to the affected area(s) should continue during any subsequent physical therapy treatments.

    Radiation Dermatitis

    • Apply a generous amount of BIAFINE® three times per day, seven days a week to the treated area(s), gently massaging the area(s) until BIAFINE® is completely absorbed.
    • BIAFINE® may be applied as indicated by the treating physician (see WARNINGS ).
    • Continue to apply BIAFINE® as described above until the skin has fully recovered.
    • Do not interrupt applications during the course of radiation therapy, even for one day.
    • Do not apply BIAFINE® 4 hours prior to a radiation session.


    BIAFINE® contains purified water, liquid paraffin, ethylene glycol monostearate, stearic acid, propylene glycol, paraffin wax, squalane, avocado oil, trolamine/sodium alginate, triethanolamine, cetyl palmitate, methylparaben (sodium salt), sorbic acid (potassium salt), propylparaben (sodium salt), and fragrance.


    BIAFINE® is supplied in tubes in the following sizes:

    45-gram tubeproduct code 0062-0205-02

    90-gram tubeproduct code 0062-0205-03

    Store at room temperature, do not freeze.

    Rx ONLY - Prescription Medical Device: Federal Law restricts this device to sale by or on the order of a physician (or properly licensed practitioner).

    Distributed by:



    Los Angeles, CA 90045

    For additional information:

    Made in France

    - To bookmark this page (add it to your favorites), please click the image to the left.
    - If you wish to link to this page, you can do so by referring to the URL address below this line.

    This page was last modified 30-JUN-07
    Copyright © 1995-2021 ITA all rights reserved.